Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. - Wikidata - awgldk - TriplyDB

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

http://www.wikidata.org/entity/Q39021270

about

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma A new clinically based staging system for perihilar cholangiocarcinoma.The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer.Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells.High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinoma A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation.A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.Role of the fibroblast growth factor receptor axis in cholangiocarcinoma.Holliday junction-recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma.Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma.High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.High expression of Parkin predicts easier recurrence of patients with adjuvant transarterial chemoembolization.Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer.Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma.High miR-718 Suppresses Phosphatase and Tensin Homolog (PTEN) Expression and Correlates to Unfavorable Prognosis in Gastric Cancer

P2860

Q26771988-378FA7AA-EDCD-411F-9C45-D578540A39B0 Q28074145-6E7F92CF-C05E-4C87-92B0-0B5B464B9346 Q33758448-450F4DBE-9A06-44C8-80A9-29A746421850 Q33888883-238325E9-7558-414E-9D98-0931D8F9F1F0 Q35124985-ECC00571-E700-40A5-82F8-C92D0D0A433F Q35659865-BEFBACAE-1123-416F-A673-4AB88C2F63BF Q35800555-92EF189F-0038-40BB-BD86-AA4E1B584A49 Q36214131-A707F946-1CB1-4F67-B67C-C43C9E30A110 Q36778814-56D49003-E70D-48B1-B694-1DD231185F55 Q37046398-7708C843-71F4-42AF-B9E7-3D68DA452F75 Q37317641-FC6AB0AE-2B8D-4305-A4B7-CB3DD79C018A Q37697146-D2B724C7-95D6-4172-863A-07AA7A552556 Q38303270-5A198FC6-4363-4D61-A36E-70C861F730B5 Q38354294-F0EA6DC1-9356-4A2F-B4DA-DC589FA92485 Q38701972-C0508338-5C65-405D-9080-EA44EF90D3C0 Q38922850-CA05CBF6-C3C6-4668-8EB9-CC1935B8283C Q38952715-4B6BD902-765D-48F2-B628-BCB62C9B2FB7 Q41145355-0EDE5958-2C53-4450-9247-E4EB1EAB4FA3 Q42364935-D499D84B-5252-4D32-83DE-B9E10E0D1C16 Q44892815-D6085D96-11F8-44A3-95C8-B408EAFF9949 Q47603972-D80EC6CF-DE62-459F-8E48-F9D7118FC1B0 Q50236833-565BCEDE-7BAD-4AF9-B87E-9FBA5B52315E Q55057384-86470286-A4E0-4C03-AD0B-91E052E7F7CC Q55195623-FBD7E26E-009A-4718-BE2C-A49AC8C107CC Q58719119-BE528210-5E58-4D6F-8651-24128EDE7DA3

P2860

Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.

http://www.wikidata.org/entity/Q39021270

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@en

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@nl

type

label

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@en

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@nl

prefLabel

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@en

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@nl

P1433

Q39021270-7CE199AD-CBA7-4527-AEB8-0A2311FE9B64

P1476

Q39021270-C16A452C-2F4B-4D1D-8C03-514B781D4FB4

P2093

Q39021270-1D8D2DA9-E7DE-4514-9B34-2D31AADDE638

Q39021270-34984160-4E23-4C20-8C9B-4E65AF00B519

Q39021270-38A01D8F-6512-4DF6-A5AF-CD750BEBFB35

Q39021270-79A10E18-AA03-4EE8-8359-AE0F970797E0

Q39021270-7EAB4A9C-61AB-44B8-A9C7-6D5B88AD01FA

Q39021270-969B6C77-DC23-4C1D-ADCA-F8A9DBB04250

Q39021270-A4F6DAD4-6107-49DD-BB0F-823B1B5522D9

Q39021270-AAD4AB21-C731-4913-9063-C12E54A18D10

Q39021270-B2C1B157-8BDB-4829-A6E3-2817FB72ADBB

Q39021270-DC69F684-1DBF-470D-84FC-7175D2B54988

P304

Q39021270-3B86747E-2851-46B0-A525-1698BD11F713

P31

Q39021270-EFCF425C-EA49-47A0-A7FA-866C346E1AFC

P356

Q39021270-31A47B5D-348B-432E-BC74-5ADB909162ED

P407

Q39021270-4E8E101A-6012-4095-85D7-D9E7FA3DCF4B

P433

Q39021270-D541AC35-7B42-422F-ACF5-9201FE5E41E3

P478

Q39021270-DFF019A2-A40A-4559-AE6C-F408B2A18312

P577

Q39021270-6E6BC796-C610-4634-9752-9C365FE32808

P698

Q39021270-262D070E-B1DE-42EA-9482-15FBF0E57D1A

P921

Q39021270-3C81926C-5B97-4914-BEAD-19F2E5085C4F

P356

J.BBRC.2014.02.050

P1433

Biochemical and Biophysical Research Communications

P1476

Fibroblast growth factor recep ...... ognosis in cholangiocarcinoma.

@en

P2093

Hui Yang

http://www.w3.org/2001/XMLSchema#string

Mohammad Iqbal

http://www.w3.org/2001/XMLSchema#string

Ning Suo

http://www.w3.org/2001/XMLSchema#string

Sen Guo

http://www.w3.org/2001/XMLSchema#string

Shang-Lei Ning

http://www.w3.org/2001/XMLSchema#string

Xiao-Fei Lu

http://www.w3.org/2001/XMLSchema#string

Xiao-Qing Yang

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

Yu-Xin Chen

http://www.w3.org/2001/XMLSchema#string

Yun-Fei Xu

http://www.w3.org/2001/XMLSchema#string

P304

54-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2014.02.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

446

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24565842

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma